Correct Answer:
Option A - Ondansetron, a potent and highly selective 5- HT3 receptor antagonist, prevents emesis following chemotherapy by antagonising the action of 5- hydroxytryptamine (5-HT) at 5- HT3 receptors on vagal afferent neurons that innervate the gastrointestinal tract and 5- HT3 receptors in the central vomiting system.
A. Ondansetron, a potent and highly selective 5- HT3 receptor antagonist, prevents emesis following chemotherapy by antagonising the action of 5- hydroxytryptamine (5-HT) at 5- HT3 receptors on vagal afferent neurons that innervate the gastrointestinal tract and 5- HT3 receptors in the central vomiting system.